title: Chemical safety, health care costs and the Affordable Care Act.
abstract: On May 22, 2013, the late Senator Frank Lautenberg (D-NJ), Senator David Vitter (R-LA) and 19 of their colleagues introduced bipartisan chemical safety legislation in the US Senate, "The Chemical Safety Improvement Act of 2013." The bill's purpose is to protect human health and the environment against the hazards of toxic chemicals, by requiring the US Environmental Protection Agency (EPA) to examine the safety of all chemicals in consumer products. The bill is currently before the Senate Committee on Environment and Public Works, chaired by Senator Barbara Boxer (D-CA). This legislation is critically important for physicians and healthcare organizations because it creates significant new opportunities to prevent disease and cut healthcare costs.
authors.affiliation: Dean for Global Health, Ethel H. Wise Professor and Chairman, Department of Preventive Medicine, Professor of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York.
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Landrigan
authors.forename: Lynn R
authors.initials: LR
authors.lastname: Goldman
mesh_terms: D062067:Chemical Safety / Q000331:legislation & jurisprudence*; D015386:Hazardous Substances / Q000009:adverse effects; D017048:Health Care Costs; D006795:Household Products; D006801:Humans; D058991:Patient Protection and Affordable Care Act; D014481:United States; D014484:United States Environmental Protection Agency / Q000331:legislation & jurisprudence*
chemical_list: D015386:Hazardous Substances
keywords: Affordable Care Act; Health Costs; Safe Chemicals Act